Exercise-Dependent Regulation of NK Cells in Cancer Protection

Trends in Molecular Medicine

Volumn 22, Issue 7, 2016, Pages 565-577

  Idorn, Manja ^a   Hojman, Pernille ^b  

^a Copenhagen University Hospital ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

exercise oncology; immune response; natural killer cells; oncology; physical training; tumor

Indexed keywords

BODY TEMPERATURE; CANCER ADJUVANT THERAPY; CANCER PREVENTION; CELL FUNCTION; CELL HYPOXIA; CELL INFILTRATION; EXERCISE; HUMAN; MOBILIZATION; NATURAL KILLER CELL; NONHUMAN; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; VASCULARIZATION; ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; KINESIOTHERAPY; LYMPHOCYTE ACTIVATION; NEOPLASMS;

ANIMALS; EXERCISE; EXERCISE THERAPY; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEOPLASMS;

EID: 84973866719     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2016.05.007     Document Type: Review

References (104)

1. 1 Tipton, C., History of Exercise Physiology. 2014, Human Kinetics ISBN-13: 9780736083690.
2. 2 Pedersen, B.K., Saltin, B., Exercise as medicine–evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand. J. Med. Sci. Sports 25 (2015), 1–72.
3. 3 Ballard-Barbash, R., et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J. Natl. Cancer Inst. 104 (2012), 815–840.
4. 4 Irwin, M.L., et al. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J. Clin. Oncol. 26 (2008), 3958–3964.
5. 5 Meyerhardt, J.A., et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24 (2006), 3527–3534.
6. 6 Friedenreich, C.M., et al. Physical activity and survival after prostate cancer. Eur. Urol., 2016, 10.1016/j.eururo.2015.12.032 Published online January 7, 2016.
7. 7 Hvid, T., et al. Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients. Cancer Cause Control 27 (2016), 165–174.
8. 8 Pedersen, L., et al. Effects of exercise on tumor physiology and metabolism. Cancer J. 21 (2015), 111–116.
9. 9 Pedersen, L., et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 23 (2016), 554–562.
10. 10 Kiessling, R., et al. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5 (1975), 112–117.
11. 11 Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
12. + T cells. Nat. Rev. Immunol. 11 (2011), 645–657.
13. 13 Robertson, M.J., Ritz, J., Biology and clinical relevance of human natural killer cells. Blood 76 (1990), 2421–2438.
14. 14 Nielsen, H.B., et al. Lymphocyte, NK and LAK cell responses to maximal exercise. Int. J. Sports Med. 17 (1996), 60–65.
15. 15 Walsh, N.P., et al. Position statement. Part one: immune function and exercise. Exerc. Immunol. Rev. 17 (2011), 6–63.
16. 16 Millard, A.L., et al. Brief exercise increases peripheral blood NK cell counts without immediate functional changes, but impairs their responses to ex vivo stimulation. Front. Immunol., 4, 2013, 125.
17. 17 Schwindt, C.D., et al. Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma?. Br. J. Sports Med. 41 (2007), 34–40.
18. 18 Nielsen, H.B., et al. Lymphocytes and NK cell activity during repeated bouts of maximal exercise. Am. J. Physiol. 271 (1996), R222–R227.
19. 19 Gabriel, H., et al. Mobilization of circulating leucocyte and lymphocyte subpopulations during and after short, anaerobic exercise. Eur. J. Appl. Physiol. Occup. Physiol. 65 (1992), 164–170.
20. 20 Timmons, B.W., Cieslak, T., Human natural killer cell subsets and acute exercise: a brief review. Exerc. Immunol. Rev. 14 (2008), 8–23.
21. 21 Shephard, R.J., Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise. Sports Med. 33 (2003), 261–284.
22. 22 Dimitrov, S., et al. Selective mobilization of cytotoxic leukocytes by epinephrine. J. Immunol. 184 (2010), 503–511.
23. 23 Kappel, M., et al. Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J. Appl. Physiol. 70 (1991), 2530–2534.
24. 24 Kappel, M., et al. Effects of elevated plasma noradrenaline concentration on the immune system in humans. Eur. J. Appl. Physiol. Occup. Physiol. 79 (1998), 93–98.
25. 25 Landmann, R., Beta-adrenergic receptors in human leukocyte subpopulations. Eur. J. Clin. Invest. 22 (1992), 30–36.
26. 26 Murray, D.R., et al. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism. Circulation 86 (1992), 203–213.
27. 27 Starkie, R.L., et al. Effect of adrenergic blockade on lymphocyte cytokine production at rest and during exercise. Am. J. Physiol. Cell Physiol. 281 (2001), C1233–C1240.
28. 28 Ogawa, K., et al. A single bout of exercise influences natural killer cells in elderly women, especially those who are habitually active. J. Strength Cond. Res. 19 (2005), 45–50.
29. 29 McFarlin, B.K., et al. Chronic resistance exercise training improves natural killer cell activity in older women. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005), 1315–1318.
30. 30 Nieman, D.C., et al. Influence of obesity on immune function. J. Am. Diet. Assoc. 99 (1999), 294–299.
31. 31 Campbell, P.T., et al. Effect of exercise on in vitro immune function: a 12-month randomized, controlled trial among postmenopausal women. J. Appl. Physiol. 104 (2008), 1648–1655.
32. 32 Simpson, R.J., et al. Exercise and the aging immune system. Ageing Res. Rev. 11 (2012), 404–420.
33. 33 Maisel, A.S., et al. Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 82 (1990), 2003–2010.
34. 34 Bigley, A.B., et al. NK-cells have an impaired response to acute exercise and a lower expression of the inhibitory receptors KLRG1 and CD158a in humans with latent cytomegalovirus infection. Brain Behav. Immun. 26 (2012), 177–186.
35. 35 Maisel, A.S., et al. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J. Clin. Invest. 85 (1990), 462–467.
36. 36 Evans, E.S., et al. Impact of acute intermittent exercise on natural killer cells in breast cancer survivors. Integr. Cancer Ther. 14 (2015), 436–445.
37. 37 Fairey, A.S., et al. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J. Appl. Physiol. 98 (2005), 1534–1540.
38. 38 Nieman, D.C., et al. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int. J. Sports Med. 16 (1995), 334–337.
39. 39 Na, Y.M., et al. Exercise therapy effect on natural killer cell cytotoxic activity in stomach cancer patients after curative surgery. Arch. Phys. Med. Rehabil. 81 (2000), 777–779.
40. 40 Beziat, V., et al. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE, 5, 2010, e11966.
41. 41 Bigley, A.B., et al. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Brain Behav. Immun. 39 (2014), 160–171.
42. 42 Benschop, R.J., et al. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br. J. Pharmacol. 113 (1994), 1311–1316.
43. 43 Catoire, M., Kersten, S., The search for exercise factors in humans. FASEB J. 29 (2015), 1615–1628.
44. 44 Pedersen, B.K., Febbraio, M.A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 (2012), 457–465.
45. 45 Benatti, F.B., Pedersen, B.K., Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat. Rev. Rheumatol. 11 (2015), 86–97.
46. 46 Rinnov, A., et al. Endurance training enhances skeletal muscle interleukin-15 in human male subjects. Endocrine 45 (2014), 271–278.
47. 47 Nielsen, A.R., et al. Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J. Physiol. 584 (2007), 305–312.
48. + T-cell function and autoimmune myositis. Skelet. Muscle, 5, 2015, 33.
49. 49 Pistilli, E.E., et al. Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J. Clin. Invest. 121 (2011), 3120–3132.
50. 50 Mortier, E., et al. IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205 (2008), 1213–1225.
51. 51 Noguchi, M., et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73 (1993), 147–157.
52. 52 Kennedy, M.K., et al. Reversible defects in natural killer and memory CD8T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191 (2000), 771–780.
53. 53 Marcais, A., et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15 (2014), 749–757.
54. 54 Donnelly, R.P., et al. mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 193 (2014), 4477–4484.
55. 55 Sinclair, L.V.R.J., et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14 (2013), 500–508.
56. bright NK cells. J. Immunol. 196 (2016), 2552–2560.
57. 57 Conlon, K.C., et al. Redistribution, hyperproliferation, activation of natural killer cells and CD8T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J. Clin. Oncol. 33 (2015), 74–82.
58. 58 Waldmann, T.A., Interleukin-15 in the treatment of cancer. Expert Rev. Clin. Immunol. 10 (2014), 1689–1701.
59. 59 Norheim, F., et al. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E1013–E1021.
60. 60 Haugen, F., et al. IL-7 is expressed and secreted by human skeletal muscle cells. Am. J. Physiol. Cell Physiol. 298 (2010), C807–C816.
61. 61 Carotta, S., et al. Identification of the earliest NK-cell precursor in the mouse BM. Blood 117 (2011), 5449–5452.
62. 62 Vosshenrich, C.A., et al. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174 (2005), 1213–1221.
63. 63 He, Y.W., Malek, T.R., Interleukin-7 receptor α is essential for the development of γδ + T cells, but not natural killer cells. J. Exp. Med. 184 (1996), 289–293.
64. + cell subsets from Id2-dependent precursors. J. Exp. Med. 207 (2010), 273–280.
65. 65 Vosshenrich, C.A., et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7 (2006), 1217–1224.
66. 66 Keller, C., et al. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J. Appl. Physiol. 99 (2005), 2075–2079.
67. dimKIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat. Commun., 5, 2014, 5639.
68. 68 Rabinowich, H., et al. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-α/β secretion. J. Immunol. 150 (1993), 4844–4855.
69. 69 Fisher, D.T., et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J. Clin. Invest. 121 (2011), 3846–3859.
70. 70 Clahsen, T., Schaper, F., Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J. Leukoc. Biol. 84 (2008), 1521–1529.
71. 71 Dethlefsen, C., et al. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res. Treat. 138 (2013), 657–664.
72. 72 Garcia, E., et al. Blood flow responses to mild-intensity exercise in ectopic versus orthotopic prostate tumors; dependence upon host-tissue hemodynamics and vascular reactivity. J. Appl. Physiol., 2016, 10.1152/japplphysiol.00266.2016 Published online April 28, 2016.
73. 73 Betof, A.S., et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J. Natl. Cancer Inst., 107, 2015, djv040.
74. 74 McCullough, D.J., et al. Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J. Natl. Cancer Inst, 106, 2014, dju036.
75. 75 McCullough, D.J., et al. Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J. Appl. Physiol. 115 (2013), 1846–1854.
76. 76 Messai, Y., et al. ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy. Cancer Res. 74 (2014), 6820–6832.
77. 77 Tittarelli, A., et al. The selective degradation of synaptic connexin 43 protein by hypoxia-induced autophagy impairs natural killer cell-mediated tumor cell killing. J. Biol. Chem. 290 (2015), 23670–23679.
78. 78 Baginska, J., et al. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 17450–17455.
79. 79 Pachynski, R.K., et al. The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J. Exp. Med. 209 (2012), 1427–1435.
80. 80 Schlecker, E., et al. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30. Cancer Res. 74 (2014), 3429–3440.
81. + immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72 (2012), 3906–3911.
82. 82 Deng, W., et al. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science 348 (2015), 136–139.
83. 83 Evans, S.S., et al. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat. Rev. Immunol. 15 (2015), 335–349.
84. 84 Burd, R., et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell. Physiol. 177 (1998), 137–147.
85. 85 Chen, Q., et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat. Immunol. 7 (2006), 1299–1308.
86. 86 Ostberg, J.R., et al. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J. Leukoc. Biol. 82 (2007), 1322–1331.
87. 87 Imai, K., et al. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356 (2000), 1795–1799.
88. 88 Zhang, L., et al. Intratumoral T cells, recurrence and survival in epithelial ovarian cancer. N. Engl. J. Med. 348 (2003), 203–213.
89. 89 Galon, J., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006), 1960–1964.
90. 90 Angell, H., Galon, J., From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers of cancer. Curr. Opin. Immunol. 25 (2013), 261–267.
91. 91 Dungan, L.S., et al. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages. Eur. J. Immunol. 44 (2014), 2903–2917.
92. H1 priming. Nat. Immunol. 5 (2004), 1260–1265.
93. 93 Topalian, S.L., et al. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27 (2015), 450–461.
94. 94 Jones, L.W., Precision oncology framework for investigation of exercise as treatment for cancer. J. Clin. Oncol. 33 (2015), 4134–4137.
95. 95 Sasso, J.P., et al. A framework for prescription in exercise-oncology research. J. Cachexia Sarcopenia Muscle 6 (2015), 115–124.
96. 96 Mishra, S.I., et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst. Rev., 8, 2012, CD008465.
97. 97 Mishra, S.I., et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst. Rev., 8, 2012, CD007566.
98. 98 Agudelo, L.Z., et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159 (2014), 33–45.
99. 99 Holmes, M.D., et al. Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005), 2479–2486.
100. 100 Kenfield, S.A., et al. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J. Clin. Oncol. 29 (2011), 726–732.
101. 101 Bezman, N.A., et al. Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 13 (2012), 1000–1009.
102. 102 Robinette, M.L., et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16 (2015), 306–317.
103. 103 Warren, H.S., Smyth, M.J., NK cells and apoptosis. Immunol. Cell Biol. 77 (1999), 64–75.
104. 104 Schmitz, K.H., et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42 (2010), 1409–1426.